The evolving pathogenesis of systemic vasculitis

Clinical Medicine

Volumn 2, Issue 5, 2002, Pages 458-464

  Savage, Caroline O S ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Antineutrophil cytoplasmic antibodies (ANCA); Autoantibodies; Endothelium; Microscopic polyangiitis; Neutrophils; Vasculitis; Wegener's granulomatosis

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOKINE; ETANERCEPT; INFLIXIMAB; MESNA; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; TUMOR NECROSIS FACTOR;

AUTOIMMUNITY; CELL INTERACTION; CELL SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG MECHANISM; DRUG PULSE THERAPY; ENDOTHELIUM CELL; HUMAN; IMMUNOPATHOGENESIS; LEUKOCYTE ACTIVATION; MAINTENANCE THERAPY; NEUTROPHIL; PATHOGENESIS; PATHOLOGY; PLASMAPHERESIS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0036760036     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.2-5-458     Document Type: Conference Paper

References (36)

1. Jennette JC, Falk RJ, Andrassy K, Bacon PA et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Review. Arthritis Rheum 1994;37:187-92.
2. Donald KJ, Edwards RL, McEvoy JDS. An ultrastructural study of the pathogenesis of tissue injury in limited Wegener's granulomatosis. Pathology 1976;8:161-9.
3. Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotising glomerulonephritis with antineutrophil antibody: A possible arbovirus aetiology? BMJ 1982;285:606.
4. Hall JB, Wadham B McN, Wood CJ, Ashton V, Adam WR. Vasculitis and glomerulonephritis: A subgroup with an antineutrophil cytoplasmic antibody. Aust NZ J Med 1984;14:277-8.
5. van der Woude FJ, Rasmussen N, Lobatto S, Wiik A et al. Auto-antibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;i:425-9.
6. Hagen EC, Daha MR, Hermans J, Andrassy K et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998;53:743-53.
7. Westman K, Selga D, Bygren P, Segelmark M et al. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody. Kidney Int 1998;53:1230-6.
8. Harper L, Cockwell P, Adu D, Savage COS. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Kidney Int 2001;59:1729-38.
9. Brooks CJ, King WJ, Radford DJ, Adu D et al. IL-1β production by human polymorphonuclear leucocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: Relevance to systemic vasculitis. Clin Exp Immunol 1996;106:273-9.
10. Cockwell P, Brooks CJ, Adu D, Savage COS. Interleukin-8: A pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. Kidney Int 1999;55:852-63.
11. Tse WY, Williams J, Pall A, Wilkes M et al. Antineutrophil cytoplasm antibody-induced neutrophil nitric oxide production is nitric oxide synthase independent. Kidney Int 2001;59:593-600.
12. Hess C, Sadallah S, Schifferli JA. Induction of neutrophil responsiveness to myeloperoxidase antibodies by their exposure to supernatant of degranulated autologous neutrophils. Blood 2000;96:2822-7.
13. Yang JJ, Preston GA, Pendergraft W, Segelmark M et al. Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants. Am J Pathol 2001;158:581-92.
14. Hattar K, Sibelius U, Bickenbach A, Csernok E et al. Subthreshold concentrations of anti-proteinase 3 antibodies (c-ANCA) specifically prime human neutrophils for fMLP-induced leukotriene synthesis and chemotaxis. J Leukoc Biol 2001;69:89-97.
15. Ralston DR, Marsh CB, Lowe MP, Wewers MD. Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, α1-antitrypsin, and Fcy receptors. J Clin Invest 1997;100:1416-24.
16. Noronha IL, Kruger C, Andrassy K, Ritz E, Waldherr R. In situ production of TNF-α, IL-1β and IL-2R in ANCA-positive glomerulonephritis. Kidney Int 1993;43:682-92.
17. Carvalho D, Savage CO, Isenberg, D, Pearson JD. IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine fashion. Arthritis Rheum 1999;42:631-40.
18. Taekema-Roelvink ME, Kooten CV, Kooij SV, Heemskerk E, Daha MT. Proteinase 3 enhances endothelial monocyte chemoattractant protein-1 production and induces increased adhesion of neutrophils to endothelial cells by upregulating intercellular cell adhesion molecule-1. J Am Soc Nephrol 2001;12:932-40.
19. Radford DJ, Savage CO, Nash GB. Treatment of rolling neutrophils with antineutrophil cytoplasmic autoantibodies causes conversion to firm integrin-mediated adhesion. Arthritis Rheum 2000;43:1337-45.
20. Radford DJ, Luu NT, Hewins P, Nash GB, Savage CO. Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells. Arthritis Rheum 2001;44:2851-61.
21. Harper L, Ren Y, Savill J, Adu D, Savage CO. Antineutrophil cytoplasmic antibodies induce reactive oxygen-dependent dysregulation of primed neutrophil apoptosis and clearance by macrophages. Am J Pathol 2000;157:211-20.
22. Savage CO, Pottinger BE, Gaskin G, Pusey CD, Pearson JD. Auto-antibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol 1992;141:335-42.
23. Ben-Smith A, Dove SK, Martin A, Wakelam MJ, Savage CO. Antineutrophil cytoplasm autoantibodies from patients with systemic vasculitis activate neutrophils through distinct signalling cascades: Comparison with conventional Fcγ receptor ligation. Blood 2001;98:1448-55.
24. Cockwell P, Howie AJ, Adu D, Savage CO. In situ analysis of C-C chemokine mRNA in human glomerulonephritis. Kidney Int 1998; 54:827-36.
25. Chakravorty SJ, Howie AJ, Cockwell P, Adu D, Savage CO. T lymphocyte adhesion mechanisms within inflamed human kidney: Studies with a Stamper-Woodruff assay. Am J Pathol 1999;154:503-14.
26. Savage CO, Harper L, Holland M. New findings in pathogenesis of anti-neutrophil cytoplasm antibody-associated vasculitis. Review. Curr Opin Rheumatol 2002;14:15-22.
27. Cunningham MA, Huang XR, Dowling JP, Tipping PG, Holdsworth SR. Prominence of cell-mediated immunity effectors in 'pauci-immune' glomerulonephritis. J Am Soc Nephrol 1999;10:499-506.
28. Hewins P, Tervaert JW, Savage CO, Kallenberg CG. Is Wegener's granulomatosis an autoimmune disease? Review. Curr Opin Rheumatol 2000; 12:3-10.
29. Xiao H, Heeringa P, Liu Z, Hu P et al. Adoptive transfer of myeloperoxidase reactive lymphocytes into recombinant activating gene-2 deficient (RAG-2 -/-) mice induces severe crescentic glomerulonephritis. J Am Soc Nephrol 2001;12:644A.
30. Jayne DRW, Rasmussen N, Andrassy K, Cohen Tervaert JVV et al. Randomised trial of cyclophosphamide versus azathioprine as remission maintenance therapy for ANCA-associated vasculitis (CYCAZAREM). N Engl J Med (submitted).
31. de Groot K, Adu D, Savage CO. The value of pulse cyclophosphamide in ANCA-associated vasculitis: Meta-analysis and critical review. Nephrol Dial Transplant 2001;16:2018-27.
32. Pusey CD, Rees AJ, Evans DJ, Peters DK, Lockwood CM. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 1991;40:757-63.
33. Kamesh L, Harper L, Savage CO. ANCA-positive vasculitis. J Am Soc Nephrol 2002;13:1953-60.
34. Reinhold-Keller E, Fink CO, Herlyn K, Gross WL, de Groot K. High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate. Arthritis Rheum 2002;47:326-32.
35. Nowack R, Gobel U, Klooker P, Hergesell O et al. Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: A pilot study in 11 patients with renal involvement. J Am Soc Nephrol 1999;10:1965-71.
36. Stegeman C, Cohen Tervaert J, de Jong P, Kallenberg CG. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 1996;335:16-20.